Reports Q4 revenue $34.5M, consensus $33.7M. “We had a breakthrough year, expanding our leadership position in voice and conversational AI ...
Hosted on MSN13m
LeMaitre (NASDAQ:LMAT) Misses Q4 Sales Targets, Stock Drops 11%Medical device company LeMaitre Vascular (NASDAQ:LMAT) in Q4 CY2024, but sales rose 14% year on year to $55.72 million. Next ...
10m
Hosted on MSNChip Stock Weakness and Tariff Angst Sink StocksThursday closed down -1.59%, the Dow Jones Industrials Index ($DOWI) (DIA) closed down -0.45% and the Nasdaq 100 Index ($IUXX ...
BURLINGTON, Mass., Feb. 27, 2025 (GLOBE NEWSWIRE) -- LeMaitre (Nasdaq:LMAT), a provider of vascular devices, implants, and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results